CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Grant or award SVP, General Counsel acquired 65,585 shares (grant or award)
- 4 Open-market sale Global Head of R&D sold 1,325 shares at $192.42 ($254,955)
- 4 Open-market sale Chief Financial Officer sold 190 shares at $192.54 ($36,583)
- 4 Open-market sale President, COO & GM China sold 1,753 shares at $192.44 ($337,356)
- 4 Grant or award Director acquired 86,216 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 355,641 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 51,688 shares (grant or award)
- 4 Grant or award Director acquired 12,922 shares (grant or award)
- 4 Open-market sale 10% owner sold 1,198,128 shares at an average $188.88 ($226,306,339)
- 4 Open-market sale 10% owner sold 2,956,689 shares at an average $201.98 ($597,183,858)
- 4 Open-market sale Global Head of R&D sold 462 shares at an average $224.74 ($103,828)
- 4 Open-market sale President, COO & GM China sold 3,291 shares at an average $224.73 ($739,599)
- 4 Open-market sale President, COO & GM China sold 7,000 shares at $253.72 ($1,776,037)
Page 11 of 29 · 580 filings